- Home
- VMO vs EMBC Comparison
VMO vs EMBC Comparison
Compare VMO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMO
- EMBC
- Stock Information
- Founded
- VMO 1992
- EMBC 1924
- Country
- VMO United States
- EMBC United States
- Employees
- VMO N/A
- EMBC N/A
- Industry
- VMO Trusts Except Educational Religious and Charitable
- EMBC Medical/Dental Instruments
- Sector
- VMO Finance
- EMBC Health Care
- Exchange
- VMO Nasdaq
- EMBC Nasdaq
- Market Cap
- VMO 612.4M
- EMBC 726.8M
- IPO Year
- VMO N/A
- EMBC N/A
- Fundamental
- Price
- VMO $9.16
- EMBC $10.45
- Analyst Decision
- VMO
- EMBC Hold
- Analyst Count
- VMO 0
- EMBC 3
- Target Price
- VMO N/A
- EMBC $17.00
- AVG Volume (30 Days)
- VMO 254.7K
- EMBC 664.3K
- Earning Date
- VMO 01-01-0001
- EMBC 05-09-2025
- Dividend Yield
- VMO 4.39%
- EMBC 5.74%
- EPS Growth
- VMO N/A
- EMBC N/A
- EPS
- VMO N/A
- EMBC 0.89
- Revenue
- VMO N/A
- EMBC $1,079,500,000.00
- Revenue This Year
- VMO N/A
- EMBC N/A
- Revenue Next Year
- VMO N/A
- EMBC $0.09
- P/E Ratio
- VMO N/A
- EMBC $11.71
- Revenue Growth
- VMO N/A
- EMBC N/A
- 52 Week Low
- VMO $7.86
- EMBC $10.20
- 52 Week High
- VMO $9.87
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- VMO 42.96
- EMBC 39.62
- Support Level
- VMO $9.05
- EMBC $10.35
- Resistance Level
- VMO $9.19
- EMBC $11.52
- Average True Range (ATR)
- VMO 0.08
- EMBC 0.65
- MACD
- VMO -0.01
- EMBC -0.14
- Stochastic Oscillator
- VMO 29.73
- EMBC 9.96
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.